Bone Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Bone Cancer, including details on symptoms, types, treatment.

Volume 2 (2005), Issue 10 (October)

1. A novel model for the investigation of orthotopically growing primary and secondary bone tumours using intravital microscopy.
   Lab Anim, 39(4): 377-83. [Abstract] [Full-text]
2. Radiation therapy for orbital lymphoma.
   Int J Radiat Oncol Biol Phys, 63(3): 866-71. [Abstract] [Full-text]
3. Clinical use of markers of bone turnover in metastatic bone disease.
   Nat Clin Pract Oncol, 2(10): 504-17; quiz 1 p following 533. [Abstract] [Full-text]
4. The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.
   Cancer Res, 65(19): 8818-25. [Abstract] [Full-text]
5. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
   Cancer Res, 65(19): 8698-705. [Abstract] [Full-text]
6. Operative management of sacral chordoma.
   J Bone Joint Surg Am, 87(10): 2211-6. [Abstract] [Full-text]
7. Primary Ewing's sarcoma of the sphenoid bone with unusual imaging features: a case report.
   Clin Neurol Neurosurg, 107(6): 528-31. [Abstract] [Full-text]
8. Imaging of posterior fossa epidermoid tumors.
   Clin Neurol Neurosurg, 107(6): 461-7. [Abstract] [Full-text]
9. Ameloblastic carcinoma containing melanocyte and melanin pigment in the mandible: a case report and review of the literature.
   J Oral Pathol Med, 34(10): 618-20. [Abstract] [Full-text]
10. Costing the components of pain management: analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): one versus five fractions for neuropathic bone pain.
    Radiother Oncol, 76(3): 264-9. [Abstract] [Full-text]
11. The application of molecular analyses for primary granulocytic sarcoma with a specific chromosomal translocation.
    Int J Hematol, 82(3): 210-4. [Abstract] [Full-text]
12. Effect of Herceptin on the development and progression of skeletal metastases in a xenograft model of human breast cancer.
    Oncogene, 24(44): 6657-66. [Abstract] [Full-text]
13. Skull-base metastases.
    J Neurooncol, 75(1): 63-9. [Abstract] [Full-text]
14. Resection of recurrent pulmonary metastases in patients with osteosarcoma.
    Cancer, 104(8): 1721-5. [Abstract] [Full-text]
15. Evaluation of pain-related behavior, bone destruction and effectiveness of fentanyl, sufentanil, and morphine in a murine model of cancer pain.
    Pharmacol Biochem Behav, 82(1): 109-19. [Abstract] [Full-text]
16. Zoledronic acid inhibits primary bone tumor growth in Ewing sarcoma.
    Cancer, 104(8): 1713-20. [Abstract] [Full-text]
17. Hypercalcemia and status epilepticus relates to salmon calcitonin administration in breast cancer.
    Breast, 14(5): 399-402. [Abstract] [Full-text]
18. Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease.
    Br J Cancer, 93(6): 633-8. [Abstract] [Full-text]
19. Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by alpha platelet-derived growth factor receptor.
    Oncogene, 24(45): 6848-54. [Abstract] [Full-text]
20. Bone deformity showing a deep coronoid notch of the mandible in a patient with neurofibromatosis type 1.
    Dentomaxillofac Radiol, 34(6): 380-3. [Abstract] [Full-text]
21. Periocular mucosa-associated lymphoid/low grade lymphomas: treatment with antibiotics.
    Am J Ophthalmol, 140(4): 729-30. [Abstract] [Full-text]
22. Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers.
    BJU Int, 96(7): 964-9. [Abstract] [Full-text]
23. The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone.
    J Orthop Res, 23(6): 1475-83. [Abstract] [Full-text]
24. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion.
    J Orthop Res, 23(6): 1467-74. [Abstract] [Full-text]
25. Effective osteosarcoma cytolysis using cytokine-induced killer cells pre-inoculated with tumor RNA-pulsed dendritic cells.
    J Orthop Res, 23(6): 1460-6. [Abstract] [Full-text]
26. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.
    Cancer Res, 65(20): 9426-35. [Abstract] [Full-text]
27. Photodynamic therapy for the treatment of metastatic lesions in bone: studies in rat and porcine models.
    J Biomed Opt, 10(3): 034011. [Abstract] [Full-text]
28. Intercellular junctions in Ewing sarcoma/primitive neuroectodermal tumor: additional evidence of epithelial differentiation.
    Mod Pathol, 18(11): 1403-10. [Abstract] [Full-text]
29. CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination.
    Radiology, 237(2): 627-34. [Abstract] [Full-text]
30. Benign and malignant processes: normal values and differentiation with chemical shift MR imaging in vertebral marrow.
    Radiology, 237(2): 590-6. [Abstract] [Full-text]
31. Primary lymphoma arising in the nasal cavity among Japanese.
    Histopathology, 47(5): 523-32. [Abstract] [Full-text]
32. A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma.
    Cancer, 104(9): 1894-900. [Abstract] [Full-text]
33. Plasma cell tumors of the skull.
    Surg Neurol, 64(5): 434-8; discussion 438-9. [Abstract] [Full-text]
34. Gamma knife radiosurgery for cavernous sinus metastases and invasion.
    Surg Neurol, 64(5): 406-10; discussion 410. [Abstract] [Full-text]
35. Squamous cell carcinoma presenting as an endodontic-periodontic lesion.
    J Periodontol, 76(10): 1798-804. [Abstract] [Full-text]
36. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons.
    Int J Radiat Oncol Biol Phys, 63(4): 1161-8. [Abstract] [Full-text]

© 2004-2008 Bone Cancer Research Today. All Rights Reserved.